← Leaderboards
Joel Barry Baseman
University Of Texas Hlth Sci Ctr San Ant
$15,953,702
Attributed
$15,953,702
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.6M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$49,554,079 · 16
By mechanism
U19$44,621,529 · 11
R01$3,960,064 · 2
T32$541,508 · 1
R21$419,375 · 1
P51$11,603 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Peter John Hart$4,421,670
- Guangming Zhong$23,302,947
- Sondra Perdue$1,207,579
- Robert G Brzyski$1,737,355
Others in their field
Top investigators on “Mycoplasma Pneumoniae”
- Michael S. Saag · University Of Alabama At Birmingham$10,845,917
- Duncan C Krause · University Of Georgia (Uga)$6,521,165
- Hong W Chu · National Jewish Health$5,724,360
- Stefano Guerra · University Of Arizona$5,387,506
- Richard J Martin · National Jewish Health$5,142,233
- Julie Gunnells Ledford · Duke University$4,693,734
Research focus
Mycoplasma PneumoniaePathologyChronicAsthmaDiagnosticLinkVirulenceAcuteInnovationToxinLeadCommunity Acquired Respiratory Distress Syndrome ToxinInfectionProteinsReagentMonitorSamplingMolecularCollaborationsChildDiagnosisFunctional DisorderAdultMycoplasma
Grant awards (77)
Role of host cell invasion in Mycoplasma genitalium persistent infection$190,625
R21 · FY2017 · AI · contact PI
Role of host cell invasion in Mycoplasma genitalium persistent infection$228,750
R21 · FY2016 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i$2,053,625
U19 · FY2015 · AI · contact PI
Infrastructure and Opportunity Fund Management$478,056
U19 · FY2015 · AI · contact PI
Biochemical, molecular and immunological characterization of Mycoplasma pneumoniae CARDS Toxin$439,452
U19 · FY2015 · AI · contact PI
Administrative Core$146,535
U19 · FY2015 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i$2,553,625
U19 · FY2014 · AI · contact PI
Infrastructure and Opportunity Fund Management$449,073
U19 · FY2014 · AI · contact PI
Biochemical, molecular and immunological characterization of Mycoplasma pneumoniae CARDS Toxin$421,119
U19 · FY2014 · AI · contact PI
Administrative Core$115,552
U19 · FY2014 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i$1,930,411
U19 · FY2013 · AI · contact PI
Infrastructure and Opportunity Fund Management$625,199
U19 · FY2013 · AI · contact PI
Biochemical, molecular and immunological characterization of Mycoplasma pneumoni$308,740
U19 · FY2013 · AI · contact PI
Administrative Core$108,202
U19 · FY2013 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i$2,033,593
U19 · FY2012 · AI · contact PI
Infrastructure and Opportunity Fund Management$1,666,109
U19 · FY2012 · AI · contact PI
Biochemical, molecular and immunological characterization of Mycoplasma pneumoni$290,872
U19 · FY2012 · AI · contact PI
Administrative Core$105,556
U19 · FY2012 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin i$3,112,198
U19 · FY2011 · AI · contact PI
Infrastructure and Opportunity Fund Management$834,904
U19 · FY2011 · AI · contact PI
Biochemical, molecular and immunological characterization of Mycoplasma pneumoni$422,422
U19 · FY2011 · AI · contact PI
Administrative Core$194,510
U19 · FY2011 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma$1,500,803
U19 · FY2010 · AI · contact PI
San Antonio STI TM CRC$591,627
U19 · FY2010 · AI · contact PI
Discretionary Projects$397,594
U19 · FY2010 · AI · contact PI
Biochemical, Molecular &Immunological Characterization of the Mycoplasma pneumon$255,848
U19 · FY2010 · AI · contact PI
Administrative Core$111,320
U19 · FY2010 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma$1,494,947
U19 · FY2009 · AI · contact PI
San Antonio STI TM CRC$547,218
U19 · FY2009 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma$407,890
U19 · FY2009 · AI · contact PI
Discretionary Projects$401,611
U19 · FY2009 · AI · contact PI
Biochemical, Molecular &Immunological Characterization of the Mycoplasma pneumon$258,433
U19 · FY2009 · AI · contact PI
Administrative Core$112,445
U19 · FY2009 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma$1,595,590
U19 · FY2008 · AI · contact PI
San Antonio STI TM CRC$747,200
U19 · FY2008 · AI · contact PI
Discretionary Projects$480,065
U19 · FY2008 · AI · contact PI
Biochemical, Molecular &Immunological Characterization of the Mycoplasma pneumon$263,053
U19 · FY2008 · AI · contact PI
Mycoplasma genitalium Persistence and Diagnosis$125,634
U19 · FY2008 · AI · contact PI
Administrative Core$110,973
U19 · FY2008 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma$1,555,324
U19 · FY2007 · AI · contact PI
San Antonio STI TM CRC$1,353,282
U19 · FY2007 · AI · contact PI
Biochemical, Molecular and Immunological Characterization of the Mycoplasma pneum$500,044
U19 · FY2007 · AI · contact PI
BIOLOGY AND PATHOGENICITY OF MYCOPLASMA GENITALIUM$403,750
R01 · FY2007 · AI · contact PI
Mycoplasma genitalium Persistence and Diagnosis$227,532
U19 · FY2007 · AI · contact PI
Administrative Core$104,530
U19 · FY2007 · AI · contact PI
San Antonio STI TM CRC$1,906,300
U19 · FY2006 · AI · contact PI
Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma$1,507,870
U19 · FY2006 · AI · contact PI
BIOLOGY AND PATHOGENICITY OF MYCOPLASMA GENITALIUM$406,915
R01 · FY2006 · AI · contact PI
Biochemical, Molecular and Immunological Characterization of the Mycoplasma pneum$220,814
U19 · FY2006 · AI · contact PI
Mycoplasma genitalium Persistence and Diagnosis$206,682
U19 · FY2006 · AI · contact PI
Administrative Core$94,151
U19 · FY2006 · AI · contact PI
MYCOPLASMA PNEUMONIAE: AIRWAY INTERPLAY$11,603
P51 · FY2006 · RR · contact PI
San Antonio STI TM CRC$1,641,907
U19 · FY2005 · AI
BIOLOGY AND PATHOGENICITY OF MYCOPLASMA GENITALIUM$410,010
R01 · FY2005 · AI
Mycoplasma genitalium Persistence and Diagnosis$207,233
U19 · FY2005 · AI
Molecular Mechanisms of Microbial Pathogenesis$118,061
T32 · FY2005 · AI
San Antonio STI TM CRC$1,236,129
U19 · FY2004 · AI
BIOLOGY AND PATHOGENICITY OF MYCOPLASMA GENITALIUM$415,617
R01 · FY2004 · AI
MYCOPLASMA PNEUMONIAE - AIRWAY INTERPLAY$325,125
R01 · FY2004 · AI
Mycoplasma genitalium Persistence and Diagnosis$207,836
U19 · FY2004 · AI
Molecular Mechanisms of Microbial Pathogenesis$111,003
T32 · FY2004 · AI
SAN ANTONIO SEXUALLY TRANSMITTED DISEASES COOPERATIVE RE$1,275,434
U19 · FY2003 · AI
MYCOPLASMA PNEUMONIAE - AIRWAY INTERPLAY$325,125
R01 · FY2003 · AI
BIOLOGY AND PATHOGENICITY OF MYCOPLASMA GENITALIUM$223,354
R01 · FY2003 · AI
Molecular Mechanisms of Microbial Pathogenesis$107,378
T32 · FY2003 · AI
SAN ANTONIO SEXUALLY TRANSMITTED DISEASES COOPERATIVE RE$1,343,450
U19 · FY2002 · AI
MYCOPLASMA PNEUMONIAE - AIRWAY INTERPLAY$325,125
R01 · FY2002 · AI
Molecular Mechanisms of Microbial Pathogenesis$106,613
T32 · FY2002 · AI
Mycoplasma genitalium--Prevalence in STDs and Pathogenesis$0
U19 · FY2002 · AI
SAN ANTONIO SEXUALLY TRANSMITTED DISEASES COOPERATIVE RE$1,614,781
U19 · FY2001 · AI
MYCOPLASMA PNEUMONIAE - AIRWAY INTERPLAY$350,125
R01 · FY2001 · AI
Molecular Mechanisms of Microbial Pathogenesis$98,453
T32 · FY2001 · AI
Mycoplasma genitalium--Prevalence in STDs and Pathogenesis$0
U19 · FY2001 · AI
SAN ANTONIO SEXUALLY TRANSMITTED DISEASES COOPERATIVE RE$1,597,173
U19 · FY2000 · AI
MECHANISMS OF MYCOPLASMA CYTADHERENCE AND INVASION$424,793
R01 · FY2000 · AI
MYCOPLASMA PNEUMONIAE - AIRWAY INTERPLAY$350,125
R01 · FY2000 · AI
Mycoplasma genitalium--Prevalence in STDs and Pathogenesis$129,053
U19 · FY2000 · AI